{"schema_version":"secwatch.filing_event.v1","accession":"0001528287-25-000021","form_type":"8-K","ticker":"NPCE","cik":"0001528287","company_name":"NeuroPace Inc","filed_at":"2025-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.235320+00:00","generated_at":"2026-05-17T14:28:43.283331+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"NeuroPace posts Q2 revenue $23.5M (+22% YoY); raises FY2025 revenue and margin guidance","bullets":["Revenue grew 22% YoY to $23.5M; RNS System revenue up 16% in Q2.","Full-year 2025 revenue guidance raised to $94-98M (previous $93-97M).","Gross margin 77.1% in Q2; FY margin guidance increased to 75-76%.","Net loss $8.7M vs $7.5M; free cash flow improved to ($2.3M).","NAUTILUS IGE study missed primary endpoint but showed 79% GTC seizure reduction at 12 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001528287-25-000021","json":"https://secwatch.observer/filing/0001528287-25-000021.json","markdown":"https://secwatch.observer/filing/0001528287-25-000021.md","text":"https://secwatch.observer/filing/0001528287-25-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1528287/000152828725000021/0001528287-25-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1528287/000152828725000021/npce-20250812.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T14:28:43.283331+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}